Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Preventions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01410552
What this trial is testing

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

Who this might be right for
Tachycardia
MicroPort CRM 1,013
Not applicableStudy completedNCT04444804
What this trial is testing

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Who this might be right for
Venous Thromboembolism
Bayer 22,153
Large-scale testing (Phase 3)Study completedNCT00766545
What this trial is testing

Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

Who this might be right for
Cerebral Infarction
Otsuka Pharmaceutical Co., Ltd. 1,095
Not applicableStudy completedNCT00924937
What this trial is testing

CORonary Diet Intervention With Olive Oil and Cardiovascular PREVention

Who this might be right for
Myocardial InfarctionUnstable AnginaMalignancy+3 more
Hospital Universitario Reina Sofia de Cordoba 1,002
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Not applicableLooking for participantsNCT06837311
What this trial is testing

Post-Stroke Secondary Prevention With Digital Monitoring

Who this might be right for
Stroke
University Hospital, Bordeaux 388
Not applicableUnknownNCT05871528
What this trial is testing

Registry of Patients With Remote Posterior cErebral Hemorrhage Following Reperfusion Treatment in Ischemic Stroke

Who this might be right for
Ischemic StrokeIntracranial HemorrhagesHemorrhagic Transformation Stroke
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 250
Not applicableUnknownNCT04841863
What this trial is testing

Secondary Prevention of Dug-related Problems Through Digital Health

Who this might be right for
Drug-Related Problems
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 200
Not applicableStudy completedNCT00122187
What this trial is testing

Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention

Who this might be right for
Colorectal Cancer
US Department of Veterans Affairs 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07440381
What this trial is testing

TriPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

Who this might be right for
Acute Coronary SyndromesSecondary PreventionLipids
Heart Care Foundation 600
Not applicableStudy completedNCT02824107
What this trial is testing

Psychosocial Risk Factors in Stroke and Myocardial Infarction

Who this might be right for
Myocardial InfarctionStroke
Centre Hospitalier Universitaire Dijon 294
Not applicableStudy completedNCT02105246
What this trial is testing

The Healthy Heart Study

Who this might be right for
Cardiac Rehabilitation
University of California, San Francisco 1,154
Large-scale testing (Phase 3)WithdrawnNCT03298958
What this trial is testing

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)Looking for participantsNCT07493304
What this trial is testing

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 1,600
Not applicableStudy completedNCT01920009
What this trial is testing

Impact of Motivational Interviews Within Pharmacy Care Upon Adherence to Cardiovascular Medicines

Who this might be right for
Coronary Heart Disease
University College, London 200
Not applicableUnknownNCT01089842
What this trial is testing

Health Coaching to Promote Physical Activity for Coronary Heart Disease Prevention

Who this might be right for
Coronary DiseaseAtherosclerosis
Corporacion Parc Tauli 262
Large-scale testing (Phase 3)Study completedNCT00799188
What this trial is testing

CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial

Who this might be right for
Cardiac TransplantationSkin Cancer
Hospices Civils de Lyon 175
Not applicableStudy completedNCT00664846
What this trial is testing

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

Who this might be right for
Stroke
Peking Union Medical College Hospital 4,000
Not applicableStudy completedNCT04343703
What this trial is testing

Suicide Prevention and Intervention in Spain: the SURVIVE Study

Who this might be right for
SuicideSuicide, AttemptedDepression
Parc de Salut Mar 1,742
Post-approval studies (Phase 4)Study completedNCT00161070
What this trial is testing

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

Who this might be right for
Brain IschemiaTransient Ischemic AttackArteriosclerosis
UMC Utrecht 4,500
Next Page